VHL, CT (Von Hippel-Lindau Disease Tumor Suppressor, pVHL, Protein G7), Rabbit

Catalog Number: USB-V2640-03J
Article Name: VHL, CT (Von Hippel-Lindau Disease Tumor Suppressor, pVHL, Protein G7), Rabbit
Biozol Catalog Number: USB-V2640-03J
Supplier Catalog Number: V2640-03J
Alternative Catalog Number: USB-V2640-03J-200
Manufacturer: US Biological
Host: Rabbit
Category: Antikörper
Application: ELISA, WB
Immunogen: Synthetic peptide selected from the C-terminal region of human VHL (KLH).
Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: ELISA: 1:1,000 Western Blot: 1:50-1:100 Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
NCBI: 000542
UniProt: P40337
Purity: Purified by ammonium sulfate precipitation.
Form: Supplied as a liquid in PBS, 0.09% sodium azide.